|
1 |
Antimicrobial therapies for chronic pain (part 2): the prevention and treatment of chronic pain
Eric J. Wang, Edward Dolomisiewicz, Jay Karri, Nuj Tontisirin, Steven P. Cohen
|
|
2 |
Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms
Eric J. Wang, Jay Karri, Nuj Tontisirin, Steven P. Cohen
Korean J Pain.2023;36(3):281-298. Published online 2023 July 1
DOI: http://dx.doi.org/10.3344/kjp.23129
|
|
3 |
The ameliorating role of sofosbuvir and daclatasvir on thioacetamide-induced kidney injury in adult albino rats
Ahmed H. Moustafa, Heba F. Pasha, Manar A. Abas, Adel M. Aboregela
Anat Cell Biol.2023;56(1):109-121. Published online 2023 March 31
DOI: http://dx.doi.org/10.5115/acb.22.200
|
|
4 |
Current scenario and future applicability of antivirals against herpes zoster
Sang Hun Kim
Korean J Pain.2023;36(1):4-10. Published online 2023 January 1
DOI: http://dx.doi.org/10.3344/kjp.22391
|
|
5 |
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
|
|
6 |
Daclatasvir와 Asunapreiver 요법에 실패한 만성 C형간염의 다른 직접작용 항바이러스제 재치료
Dong Hoon Lee, Soo Hyung Ryu, Hee jun Myung, Yun Jae Shin, Si Hyeong Lee, Tae Young Park, Jeong Seop Moon
|
|
7 |
Zoster sine herpete: a review
Junli Zhou, Juan Li, Lulin Ma, Song Cao
|
|
8 |
Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
Hyun Woong Lee
|
|
9 |
Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
J Liver Cancer.2019;19(2):128-135. Published online 2019 September 30
DOI: http://dx.doi.org/10.17998/jlc.19.2.128
|
|
10 |
The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study
Seong Jun Park, Ah Ran Kim, Won Hyeok Choe, Jeong Han Kim, Byung Chul Yoo, So Young Kwon
|
|
11 |
Direct Antiviral Mechanisms of Interferon-Gamma
Soowon Kang, Hailey M. Brown, Seungmin Hwang
Immune Netw.2018;18(5):e33. Published online 2018 October 17
DOI: http://dx.doi.org/10.4110/in.2018.18.e33
|
|
12 |
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
Jong Man Kim, Kwang-Woong Lee, Dong-Hyun Sinn, Gyu-Seong Choi, Nam-Joon Yi, Choon Hyuck David Kwon, Kyung-Suk Suh, Jae-Won Joh
|
|
13 |
Therapeutic Efficacy of Lamivudine in Children and Adolescents with Chronic Hepatitis B
Yujung Choi, Kil Seoung Bae, Ki Hwan Kim, Dae Kyun Koh, Jong-Hyun Kim
|
|
14 |
2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis C: What's New?
Kyung-Ah Kim
|
|
15 |
An Uncommon Case of Bilateral Pathologic Hip Fractures: Antiviral Drug-induced Osteomalacia in a Patient with Hepatitis B
Nam Hoon Moon, Won Chul Shin, Min Uk Do, Hyung Joon Cho, Kuen Tak Suh
Hip Pelvis.2018;30(2):109-114. Published online 2018 June 4
DOI: http://dx.doi.org/10.5371/hp.2018.30.2.109
|
|
16 |
Comprehensive review and update on herpes zoster
Young Min Park
|
|
17 |
Anti-infective potential of catechins and their derivatives against viral hepatitis
Jae-Min Song
|
|
18 |
Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal
|
|
19 |
Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Indications for Treatment
Kyung-Ah Kim
|
|
20 |
Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3
Young Kul Jung
|
|